Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Medicimon AB
AB
Active
Org 5593197915
Greta Garbos Väg 21 C
General medical practice activities · NACE 8621
Est. 2021
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 894K
+104% vs 2024
EBITDA margin
20.9%
+364% vs 2024
Equity ratio
36.3%
Financial strength
Net profit 2025
SEK 136K
+2200% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 894K
+104%
EBITDA
SEK 187K
+364%
Net profit
SEK 136K
+2200%
Total assets
SEK 500K
+165%
Equity
SEK 181K
+297%
Employees
1
—
Company information
Legal name
Medicimon AB
Org number
5593197915
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
28 maj 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva medicinsk konsultverksamhet samt kapital- och fastighetsförvaltning samt därmed förenlig verksamhet.
Contact
Address
Greta Garbos Väg 21 C
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Solna
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
0M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
587
1 266
1 348
437
894
Staff expenses
—
−695
−813
−451
−638
EBITDA
187
456
466
−71
187
Depreciation & amort.
−0
—
—
—
—
EBIT
187
456
466
−71
187
Net financials
—
0
2
0
−12
Profit before tax
187
342
468
9
175
Tax
−39
−71
−97
−3
−39
Net profit
148
271
370
6
136
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
351
944
958
188
500
Equity
173
445
395
46
181
Long-term debt
0
—
—
—
—
Short-term debt
177
385
448
109
285
Total debt
177
385
448
109
285
Financial ratios
5-year trend
EBITDA margin
20.9%
This company
15.8%
Market median
+32% vs market
2021
2025
Equity ratio
36.3%
This company
38.2%
Market median
+5% vs market
2021
2025
Return on equity
74.8%
This company
18.4%
Market median
+307% vs market
2021
2025
Net profit margin
15.2%
This company
8.1%
Market median
+88% vs market
2021
2025
Asset turnover
1.79×
This company
1.12×
Market median
+60% vs market
2021
2025
Debt / equity
1.76×
This company
0.62×
Market median
-184% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
SD
Simon Daniel Salomonsson
Board of Directors
2022
DL
Dan Lennarth Salomonsson
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Medicimon AB also hold positions in
0
other companies.
Person
Role here
Other companies
Simon Daniel Salomonsson
Board of Directors
0 companies
Dan Lennarth Salomonsson
Deputy Board Member
0 companies